Howard A Burris, Iii

Title: Howard A Burris, III: Innovator in Cancer Treatment

Introduction

Howard A Burris, III is a notable inventor based in Nashville, TN (US). He has made significant contributions to the field of oncology through his innovative research and patent work. His dedication to improving cancer treatment has led to the development of methods that could potentially change the lives of patients suffering from malignant gliomas and secondary brain tumors.

Latest Patents

Howard A Burris, III holds a patent for the "Use of dianhydrogalactitol and analogs and derivatives thereof to treat recurrent malignant glioma or progressive secondary brain tumor." This patent outlines methods and compositions suitable for treating malignancies such as recurrent glioma and progressive secondary brain tumors. The methods employ a hexitol derivative, specifically dianhydrogalactitol, along with its derivatives or analogs, including diacetyldianhydrogalactitol. The compositions can incorporate these hexitol derivatives, showcasing his innovative approach to cancer treatment.

Career Highlights

Burris is associated with Del Mar Pharmaceuticals (BC) Ltd., where he continues to work on advancing cancer therapies. His research focuses on developing effective treatments that can improve patient outcomes in the face of challenging malignancies. His work is characterized by a commitment to scientific excellence and a passion for helping those affected by cancer.

Collaborations

Some of his notable coworkers include Dennis M Brown and Kent C Shih. Their collaborative efforts contribute to the innovative research environment at Del Mar Pharmaceuticals, fostering advancements in cancer treatment.

Conclusion

Howard A Burris, III is a dedicated inventor whose work in cancer treatment exemplifies the impact of innovation in medicine. His patent on dianhydrogalactitol and its derivatives represents a significant step forward in the fight against malignant gliomas and secondary brain tumors. His contributions continue to inspire advancements in oncology and improve the lives of patients.